New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 75mg;  ;   - modified release tablet - 75 mg - active: diclofenac sodium 75mg     excipient: cetyl alcohol colloidal silicon dioxide hypromellose pigment suspension, white pigment suspension, red macrogol 8000 magnesium stearate opacode black s-1-17823 polysorbate 80 povidone purified talc sucrose - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - diclofenac sodium 12.5 mg - suppository

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - diclofenac sodium 50 mg - suppository

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - diclofenac sodium 100 mg - suppository

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - diclofenac sodium 25 mg - gastro-resistant tablet

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - diclofenac sodium 50 mg - gastro-resistant tablet

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - diclofenac sodium 50 mg - dispersible tablet

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - diclofenac sodium 75 mg - modified-release tablet

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - diclofenac sodium 100 mg - modified-release tablet

Australia - English - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - voriconazole -